Videos | Stents Bioresorbable
Stephen Ellis, M.D., professor of medicine and director of interventional cardiology at Cleveland Clinic, discusses the ...
March 30, 2017
News | Radiation Dose Management
The Connecticut Hospital Association (CHA) and Bayer announced an alliance to establish the United States' first-ever statewide radiation dose management repository for patients undergoing certain radiological procedures. The repository will use Bayer’s Radimetrics, a radiation and contrast dose management and analytics tool which provides clinicians with data needed for them to help ensure their patients receive the lowest radiation dosage necessary. The goal is for clinicians to be able to share the data in order to benchmark radiation exposure.
March 30, 2017
News
March 30, 2017 — New late-breaking featured clinical research presented today adds strong clinical support for Abbott's ...
March 30, 2017Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News | Defibrillator Monitors
Automated external defibrillators (AEDs) are associated with increased survival of sudden cardiac arrest when installed in schools, yet only 17 out of 50 U.S. states require AED installation in at least some of their schools, according to a new analysis. The analysis was published in the Journal of the American College of Cardiology.
March 30, 2017
News | Patient Monitors
Acarix AB recently announced the results from a new multi-center trial of its handheld CADScor System for non-invasive, non-radiation acoustic detection of coronary artery disease (CAD). The results were presented at the American College of Cardiology (ACC) 2017 Annual Scientific Meeting, held March 17-19 in Washington, D.C., and showed the handheld CADScor System rules out CAD with 97 percent negative predictive value. The results confirm the company’s previously announced figures which, prior to this study, were unconfirmed.
March 30, 2017
Feature | Left Atrial Appendage (LAA) Occluders
March 29, 2017 — For patients with atrial fibrillation (AFib), closing the area of the heart known as the left atrial ...
March 29, 2017Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature | Atrial Fibrillation
March 29, 2017 — Uninterrupted treatment with dabigatran (Pradaxa), a non-vitamin K, novel antagonist oral anticoagulant ...
March 29, 2017
News | Pharmaceuticals
Injection of a novel form of synthetic high-density lipoprotein cholesterol (HDL-C), or good cholesterol, into the arteries of recent heart attack patients did not reduce the volume of plaque in the arteries compared with placebo injections, according to new research. The findings were presented at the American College of Cardiology’s 66th Annual Scientific Sessions, March 17-19 in Washington, D.C.
March 29, 2017
News | Chronic Total Occlusion (CTO) | Dave Fornell
March 29, 2017 — In patients with a complete, persistent arterial blockage, medication alone was found to be equal to ...
March 29, 2017Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Videos | Cath Lab
MDBuyline analyst Tom Watson shares some of the most important trends in cardiac technology he saw at the 2017 American ...
March 28, 2017
News | Defibrillator Monitors
Philips and the U.S. Food and Drug Administration (FDA) announced the company has initiated a recall of its HeartStart MRx Monitor/Defibrillator. The Class I recall is due to electrical and battery connection issues that may prevent the device from powering up, charging and delivering electrical shock therapy. The device may also unexpectedly stop pacing. A delay in delivering therapy could result in serious patient injury such as permanent organ damage, brain injury or death.
March 28, 2017
News | Pharmaceuticals
When used as a preventive measure during heart surgery, the heart failure drug levosimendan did not significantly reduce rates of death, heart attack, kidney dialysis or use of a mechanical assist device among patients at high risk for low cardiac output syndrome. These findings were part of a study presented at the American College of Cardiology’s 66th Annual Scientific Session, March 17-19 in Washington, D.C.
March 28, 2017Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | Ultrasound Imaging
Young rabbits exposed to ultrasound during fetal development had weaker thighbones than unexposed rabbits, according to a study published in the Pertanika Journal of Science & Technology. While the finding applies to a relatively small group of test subjects, 142 young rabbits, it raises questions about the rising use of prenatal ultrasounds in women worldwide.
March 28, 2017
Feature | Cath Lab
March 27, 2017 — Patients experiencing a major heart attack often have more than one clogged artery, but under current ...
March 27, 2017
News | Hypertension
Participants in Web-based lifestyle counseling reduced their systolic blood pressure by 10 mmHg, compared with a 6 mmHg reduction for those taking part in a web-based control intervention, a statistically significant difference, according to a new study. The research from this trial — the first randomized, double-blinded trial of an online behavioral intervention for high blood pressure — was presented at the American College of Cardiology’s 66th Annual Scientific Session, March 17-19 in Washington, D.C.
March 27, 2017© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now